Novo Nordisk Clinical Trials
-
Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
-
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow -
-
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Help
-
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1
-
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins i
-
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibit
-
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insu
-
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and
-
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhi
-
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to
-
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial D
-
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Re
-
A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compare
-
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Rang
-
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a H
Trials by company
PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan